Large U.S. CRE Deals Make a Powerful Comeback in Q3 2025

City skyline sunrise

After a sluggish start to 2025, the commercial real estate world finally exhaled. According to new research from Altus Group, large single‑asset CRE deals — those valued above $10 million — surged back to life in Q3 2025. With more than $76 billion in transactions, this quarter delivered the most impressive rebound in over a decade, signaling a renewed sense of investor confidence across the country.

For real estate professionals, investors, and emerging industry leaders (including many developing their expertise at Cameron Academy), this resurgence provides a clear message: capital is flowing again — and at scale.

Source Highlight: Dive deeper into the full market findings at Altus Group: Q3 2025 CRE Investment & Transactions Report

The Return of the Major Deal

For the first time in several quarters, both annual and quarterly traded‑property counts saw meaningful increases. But the true headline lies in which deals made their comeback. Large single‑asset transactions roared back, totaling 1,826 trades above $10 million — the highest since Q3 2022.

These big‑ticket trades accounted for 67.8% of all single‑asset dollar volume, a level not reached since mid‑2022 and slightly surpassing the highs of late 2018. In short: major players are re‑entering the market.

How Big Was the Rebound?

Large-deal momentum surged across every measurable metric:

  • Up 48% quarter‑over‑quarter
  • Up 41% year‑over‑year
  • Up 15.9% on a trailing four‑quarter basis

This represents the most robust growth in large‑asset trading since 2015 (excluding the unusual post‑pandemic surge).

Why Overall Volume Still Lags 2021–2022 Highs

Even with the resurgence, total transaction volume hasn’t quite matched the peaks of 2021 and early 2022 — primarily because median deal sizes remain smaller. The median large CRE deal in Q3 2025 landed at $19.6 million, roughly 9% below the late‑2021 cycle peak.

Sector‑specific breakdown reveals even more nuance:

  • Industrial: $18.9M (1.7% below peak)
  • Multifamily: $29.3M (8.2% below peak)
  • Retail: $15.5M (6.1% below peak)
  • Office: $18.1M (23.8% below peak — still the market laggard)

However, the median large‑deal size has climbed a solid 4.7% since its post‑pandemic low in late 2023, with multifamily leading the recovery.

Pricing Trends and Stabilization

The median price per square foot improved modestly across most property types, increasing 0.6% quarter‑over‑quarter and year‑over‑year. Office properties continued to face pressure, declining 3% on the quarter and 4.4% annually, while multifamily assets posted a healthy 5% annual increase.

A Step Toward Normalcy

The return of large single‑asset CRE transactions signals more than volume: it represents a renewed sense of investor certainty, clearer pricing expectations, and strengthened liquidity at the top of the market.

As the year wraps up, one question looms: Is this the start of a sustained recovery — or simply a temporary surge before the next slowdown?

Regardless, Q3 2025 stands as the most convincing evidence in years that the upper tier of the CRE landscape is regaining its footing — excellent news for brokers, lenders, investors, and professionals preparing for future opportunities.

For complete datasets, visualizations, and sector‑by‑sector deep dives, visit the full Altus Group quarterly analysis:
US CRE Investment & Transactions Report

Professionals seeking to stay sharp as the market evolves can elevate their credentials and readiness through Cameron Academy — Florida’s trusted destination for real estate education, professional licensing, and continuing education across dozens of industries nationwide.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Gene Editing: A Promising Frontier in Biotechnology

Gene editing technology is swiftly emerging as a transformative force in both healthcare and agriculture, particularly through tools like CRISPR-Cas9, which offer precise methods to modify genes and promise to revolutionize treatment for genetic disorders, cancer, and infectious diseases.

Empowering the Gig Economy: AXA’s Tailored Protection

Angela Wong, Chief Marketing and Customer Officer at AXA Hong Kong & Macau, underscores the critical need for comprehensive insurance solutions for gig workers.

By |November 24, 2024|Categories: Article, Business, Insurance|Tags: , |0 Comments

Ethical Deployment of AI in Healthcare: AMA’s Guiding Strategies

The AMA highlights that AI's integration must be guided by the fundamental principles of medical ethics: patient autonomy, beneficence, nonmaleficence, and justice.

By |November 24, 2024|Categories: Article, Healthcare, Technology Ethics|Tags: , |0 Comments

AI’s Role in Revolutionizing Medical Education

AI, which simulates human intelligence, is reshaping various sectors, particularly healthcare. The ability to perform complex tasks, such as diagnostics and personalized healthcare, is no longer confined to human capabilities alone.

By |November 23, 2024|Categories: Article, Education, Technology|Tags: , |0 Comments

AI Chatbots in Chronic Disease Diagnosis

A recent study published in Nature on July 25, 2024, unveils a cutting-edge chatbot named Chat Ella, designed to assist in the diagnosis of chronic diseases.

Revolutionizing Genetic Research with CRISPR-Cas Technology

CRISPR-Cas technology is not just a tool but a gateway to understanding the genetic influences on diseases.